---
figid: PMC9693654__jitc-2022-005132f02
pmcid: PMC9693654
image_filename: jitc-2022-005132f02.jpg
figure_link: /pmc/articles/PMC9693654/figure/F2/
number: Figure 2
figure_title: ''
caption: 'Gene expression analysis of patients who reached a complete response versus
  other patients. The triangle shape indicate the following genes: protumor genes
  (red), immune suppressor pathway (gray), apoptosis pathway (yellow), antitumor genes
  (green), immune activation pathway (blue) and genes related with drug concentration
  (black). Genes marked with asterisk are related to drug concentration.'
article_title: 'Nivolumab serum concentration in metastatic melanoma patients could
  be related to outcome and enhanced immune activity: a gene profiling retrospective
  analysis.'
citation: Domenico Mallardo, et al. J Immunother Cancer. 2022;10(11):e005132.
year: '2022'

doi: 10.1136/jitc-2022-005132
journal_title: Journal for Immunotherapy of Cancer
journal_nlm_ta: J Immunother Cancer
publisher_name: BMJ Publishing Group

keywords:
- Melanoma
- Immunotherapy
- Tumor Biomarkers

---
